fda bpc-157 not approved warning statement and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded FDA to weigh easing limits

[DOI] [Google Scholar] 20.Dufes C., Olivier J.-C., Gaillard F., Gaillard A., Couet W., Muller J.-M

2 (2011): 280289, 10.1016/J.EXPNEUROL.2011.09.018

G.PenuelaE

3, 4, 5 Traditionally, mast cells and immunoglobulin E (IgE) have long been associated with the pathogenesis of immediate hypersensitivity reaction, the pathophysiologic hallmark of allergic rhinitis, allergic asthma, and anaphylaxis

[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Taishi P, Churchill L, De A, Obal F, Jr., Krueger JM

Researchers proposed that BPC-157s anti-inflammatory properties and its ability to stimulate angiogenesis may create conditions more favorable to neuronal repair in the post-injury environment